| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/04/2002 | WO2002030205A3 Treatment of transgenic corn seeds with pesticides |
| 07/04/2002 | WO2002029023A8 Nicastrin protein |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002023202A8 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 07/04/2002 | WO2002014473A8 Animals expressing exogenous igf-i in their milk |
| 07/04/2002 | WO2002014363A3 Influencing the distribution of metals in transgenic plants |
| 07/04/2002 | WO2002012478A8 Methyl-d-erythritol phosphate pathway genes |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins |
| 07/04/2002 | WO2002006495A3 Mutant muscle-specific enhancers |
| 07/04/2002 | WO2002005205A8 Method and system for modeling biological systems |
| 07/04/2002 | WO2002004953A8 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2002000870A3 Method for transfecting cells using a magnetic field |
| 07/04/2002 | WO2002000861A3 Human beta-ketoacyl synthase (46619) and uses thereof |
| 07/04/2002 | WO2002000859A3 46508, a novel human peptidyl-trna hydrolase family member and uses thereof |
| 07/04/2002 | WO2002000700A3 Regulation of human p2y8-like g protein-coupled receptor |
| 07/04/2002 | WO2002000677A8 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001098525A3 Frozen tissue microarrays and methods for using the same |
| 07/04/2002 | WO2001096535A3 Nucleic acid coding for a bonding site of a protein kinase of the mitogenic signalling cascade of a glycolysis-catalysing enzyme |
| 07/04/2002 | WO2001096532A3 Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast |
| 07/04/2002 | WO2001096392A8 22109, a novel human thioredoxin family member and uses thereof |
| 07/04/2002 | WO2001094588A3 Gene (cur) related to a curly phenotype in plants |
| 07/04/2002 | WO2001094400A3 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 07/04/2002 | WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001088109A3 Model for neurodegenerative disease |
| 07/04/2002 | WO2001088089A3 Single copy genomic hybridization probes and method of generating same |
| 07/04/2002 | WO2001085974A3 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 07/04/2002 | WO2001085969A3 Genetic transformation in plants using site-specific recombination and wide hybridization |
| 07/04/2002 | WO2001083563A3 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha |
| 07/04/2002 | WO2001081414A3 Integrin alpha subunit and uses thereof |
| 07/04/2002 | WO2001079481A3 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | WO2001077298A3 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 07/04/2002 | WO2001077175A3 G protein-coupled receptors |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001070979A3 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
| 07/04/2002 | WO2001064886A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/04/2002 | WO2001059089A3 Improved galactosylation of recombinant glycoproteins |
| 07/04/2002 | WO2001059063A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001057207A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/04/2002 | WO2001055364A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055328A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055325A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055322A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055321A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055318A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055311A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055308A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001046420A8 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 07/04/2002 | WO2001044515A9 Apparatus for performing biological reactions |
| 07/04/2002 | WO2001042512A3 Normalization controls and duplex probes for quantitative hybridization reactions |
| 07/04/2002 | WO2001042470A9 Nucleic acid and protein expressed thereby and their involvement in stress |
| 07/04/2002 | WO2001038510A3 Integration vectors and method for producing recombinant proteins in fungi |
| 07/04/2002 | WO2001037643A9 Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes |
| 07/04/2002 | WO2001036589A9 Human ex vivo immune system |
| 07/04/2002 | WO2001035100A9 Binding acceleration techniques for the detection of analytes |
| 07/04/2002 | WO2001034815A9 Dsrna as insect control agent |
| 07/04/2002 | WO2001034808A3 Method of large-scale production and method of testing of the biological activity of a substance from soybean |
| 07/04/2002 | WO2001034806A9 Methods and compositions for screening using diphtheria toxin constructs |
| 07/04/2002 | WO2001032673A9 Sequences encoding human neoplastic marker |
| 07/04/2002 | WO2001025441A3 Tumour-specific vector for gene therapy |
| 07/04/2002 | WO2000074687A9 Antisense modulation of b7 protein expression |
| 07/04/2002 | WO2000073316A3 Virus immunologic determinants |
| 07/04/2002 | WO2000071739A9 Reverse transcription activity from bacillus stearothermophilus dna polymerase in the presence of magnesium |
| 07/04/2002 | WO2000071729A9 Recombinant hosts suitable for simultaneous saccharification and fermentation |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | WO2000068396A9 Bacillus circulans xylanase mutants |
| 07/04/2002 | WO2000024871A3 Kv BETA 1.1-DEFICIENT MICE WITH IMPAIRED LEARNING |
| 07/04/2002 | WO2000022430A9 Neisseria genomic sequences and methods of their use |
| 07/04/2002 | US20020088029 Genetically engineering plant cells; obtain cell, incubate with agrobacterium, heat, recover and propagate transformed plant |
| 07/04/2002 | US20020088028 Identification and characterization of a DWARF AND LATE FLOWERING 2 phenotype ( DLF2) in arabidopsis |
| 07/04/2002 | US20020088027 Expression of biologically active polypeptides in duckweed |
| 07/04/2002 | US20020088026 Plant RNaseD-like genes |
| 07/04/2002 | US20020088025 Expressing preferential protein in cells; obtain cell, transform with expression vector containing preferential polypeptides, propagate cells, recover polypeptides |
| 07/04/2002 | US20020088024 Nucleotide sequences coding enzymatic protein for use in the treatment of lysosomal storage defects |
| 07/04/2002 | US20020088023 Nucleotide sequences coding enzymatic protein for use in generating plants with amplified starch biosynthesis |
| 07/04/2002 | US20020088022 Nucleotide sequences coding preferential protein for use in the generation of disease resistant plants |
| 07/04/2002 | US20020088021 Mucleotide sequences coding polypeptide for use in detection of nucleotide sequence mutation |
| 07/04/2002 | US20020088020 Corn plants and products with improved oil composition |
| 07/04/2002 | US20020088018 Transgenic mice containing MAS orphan receptor gene disruptions |
| 07/04/2002 | US20020088017 Genetically engineered rodents; for use as anima,l models for evaluating respiratory, nervous system, cardiovascular, vascular, kidney, bone, reproductive and immunological disorders |
| 07/04/2002 | US20020088016 Murine expression of a human IgA lambda locus |
| 07/04/2002 | US20020088014 Minimal adenovirus mediated recombinant vaccine |
| 07/04/2002 | US20020088012 Nucleotide sequences for use in the prevention of microorganismal infections |
| 07/04/2002 | US20020086989 Photoactivatable nucleic acid derivatives |
| 07/04/2002 | US20020086988 Polypeptide for use as tools in human therapeutics and diagnostics |
| 07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 07/04/2002 | US20020086986 Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon |
| 07/04/2002 | US20020086982 Novel EBI-3-ALT protein and nucleic acid molecules and uses therefor |
| 07/04/2002 | US20020086981 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086978 Specific binding agents |
| 07/04/2002 | US20020086975 P2u2 receptor antibodies |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086849 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/04/2002 | US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy |
| 07/04/2002 | US20020086846 Gene transfer to renal glomerular cells |
| 07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |